Aytu BioScience
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $16,221 | $16,574 | $17,976 | $17,993 |
Gross Profit | 10,786 | 11,985 | 11,906 | 11,693 |
EBITDA | 2,634 | 3,919 | -5,980 | -842 |
EBIT | 1,461 | 2,492 | -7,924 | -2,642 |
Net Income | 788 | 1,474 | -4,617 | -2,890 |
Net Change In Cash | 16,221 | 16,574 | 17,976 | 17,993 |
Free Cash Flow | 2,899 | -1,326 | -788 | -254 |
Cash | 20,398 | 20,108 | 20,006 | 19,760 |
Basic Shares | 8,485 | 9,099 | 5,537 | 5,530 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $81,002 | $107,399 | $96,669 | $65,632 |
Gross Profit | 54,586 | 66,632 | 52,283 | 29,200 |
EBITDA | -1,012 | -3,514 | -27,957 | -14,491 |
EBIT | -9,284 | -12,329 | -38,103 | -14,727 |
Net Income | -15,844 | -17,050 | -108,780 | -58,289 |
Net Change In Cash | 81,002 | 107,399 | 96,669 | 65,632 |
Free Cash Flow | -1,388 | -5,129 | -28,823 | -28,305 |
Cash | 20,006 | 22,985 | 19,360 | 49,649 |
Basic Shares | 5,537 | 3,340 | 1,470 | 837 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.13 |
2024-09-30 | -$0.15 |
2024-06-30 | -$0.82 |
2024-03-31 | -$0.52 |
